Steven Shak, Chief Scientific Officer at GENOMIC HEALTH INC (GHDX), sold 49,579 shares at $74.28 ($3.7M) on 2019-01-31, disclosed to the SEC on 2019-02-01.
Seasonal sale ($3.7M) by Chief Scientific Officer — this insider has traded GHDX in January in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $72.01 | 3,101 | $223K | 6.1% |
| 2 | $73.12 | 10,215 | $747K | 20.3% |
| 3 | $74.20 | 11,418 | $847K | 23.0% |
| 4 | $73.58 | 1,808 | $133K | 3.6% |
| 5 | $74.28 | 5,364 | $398K | 10.8% |
| 6 | $75.33 | 17,673 |
| $1.3M |
| 36.2% |
| Total | $74.23 avg | 49,579 | $3.7M | 100% |
| Filing → |
| GHDX | SELL | 2019-08-05 | $3.6M | — | Filing → |
| GHDX | SELL | 2019-07-10 | $2.8M | — | Filing → |
| GHDX | SELL | 2019-05-10 | $1.4M | — | Filing → |